These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8609215)

  • 1. Glucose-induced phosphorylation of the insulin receptor. Functional effects and characterization of phosphorylation sites.
    Pillay TS; Xiao S; Olefsky JM
    J Clin Invest; 1996 Feb; 97(3):613-20. PubMed ID: 8609215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid induced insulin resistance in rat-1 fibroblasts overexpressing human insulin receptors: impaired insulin-stimulated mitogen-activated protein kinase activity.
    Usui I; Takata Y; Imamura T; Morioka H; Sasaoka T; Sawa T; Ishihara H; Ishiki M; Kobayashi M
    Diabetologia; 1997 Aug; 40(8):894-901. PubMed ID: 9267983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
    Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
    Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Raf-1 kinase and protein kinase C zeta in insulin-like growth factor I-induced brown adipocyte mitogenic signaling cascades: inhibition by cyclic adenosine 3',5'-monophosphate.
    Valverde AM; Teruel T; Lorenzo M; Benito M
    Endocrinology; 1996 Sep; 137(9):3832-41. PubMed ID: 8756554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling. Evidence from transfection studies.
    Almind K; Inoue G; Pedersen O; Kahn CR
    J Clin Invest; 1996 Jun; 97(11):2569-75. PubMed ID: 8647950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the mitogen-activated protein kinase/90-kilodalton ribosomal protein S6 kinase signaling pathway in 3T3-L1 adipocytes and its role in insulin-stimulated glucose transport.
    Fingar DC; Birnbaum MJ
    Endocrinology; 1994 Feb; 134(2):728-35. PubMed ID: 8299568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lovastatin inhibits the stimulation of mitogen-activated protein kinase by insulin in HIRcB fibroblasts.
    Xu XQ; McGuire TF; Blaskovich MA; Sebti SM; Romero G
    Arch Biochem Biophys; 1996 Feb; 326(2):233-7. PubMed ID: 8611028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-3 and IL-4 activate cyclic nucleotide phosphodiesterases 3 (PDE3) and 4 (PDE4) by different mechanisms in FDCP2 myeloid cells.
    Ahmad F; Gao G; Wang LM; Landstrom TR; Degerman E; Pierce JH; Manganiello VC
    J Immunol; 1999 Apr; 162(8):4864-75. PubMed ID: 10202031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
    Band CJ; Posner BI; Dumas V; Contreres JO
    Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of phosphotyrosyl-IRS-1 level and insulin receptor tyrosine kinase activity on insulin-stimulated phosphatidylinositol 3, MAP, and S6 kinase activities.
    Wilden PA; Broadway DE
    J Cell Physiol; 1995 Apr; 163(1):9-18. PubMed ID: 7896903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The level of insulin receptor tyrosine kinase activity modulates the activities of phosphatidylinositol 3-kinase, microtubule-associated protein, and S6 kinases.
    Wilden PA; Kahn CR
    Mol Endocrinol; 1994 May; 8(5):558-67. PubMed ID: 8058065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action.
    Mothe I; Van Obberghen E
    J Biol Chem; 1996 May; 271(19):11222-7. PubMed ID: 8626671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.
    De Fea K; Roth RA
    Biochemistry; 1997 Oct; 36(42):12939-47. PubMed ID: 9335553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis for the insulinomimetic effects of C-peptide.
    Grunberger G; Qiang X; Li Z; Mathews ST; Sbrissa D; Shisheva A; Sima AA
    Diabetologia; 2001 Oct; 44(10):1247-57. PubMed ID: 11692173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells.
    Andreozzi F; Laratta E; Sciacqua A; Perticone F; Sesti G
    Circ Res; 2004 May; 94(9):1211-8. PubMed ID: 15044323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine phosphorylation of phosphoinositide-dependent kinase 1 by the insulin receptor is necessary for insulin metabolic signaling.
    Fiory F; Alberobello AT; Miele C; Oriente F; Esposito I; Corbo V; Ruvo M; Tizzano B; Rasmussen TE; Gammeltoft S; Formisano P; Beguinot F
    Mol Cell Biol; 2005 Dec; 25(24):10803-14. PubMed ID: 16314505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of protein kinase C alpha inhibits insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1.
    Chin JE; Liu F; Roth RA
    Mol Endocrinol; 1994 Jan; 8(1):51-8. PubMed ID: 7512195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
    Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
    Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation of the two carboxyl-terminal tyrosines in the insulin receptor results in enhanced activation of mitogen-activated protein kinase.
    Pang L; Milarski KL; Ohmichi M; Takata Y; Olefsky JM; Saltiel AR
    J Biol Chem; 1994 Apr; 269(14):10604-8. PubMed ID: 8144649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
    Zapf-Colby A; Eichhorn J; Webster NJ; Olefsky JM
    Oncogene; 1999 Sep; 18(35):4908-19. PubMed ID: 10490825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.